Pharma news
Asia
A recent case in India reveals the various ways in which pharmaceutical patents can be challenged, as Neeti Wilson, Arpita Kulshreshtha and Gitika Suri of Anand and Anand report. 2 October 2018
Americas
Dykema has strengthened its Minneapolis, Minnesota office with the addition of two lawyers from Moore & Hansen as senior counsel. 2 October 2018
Pharma
Crowell & Moring has welcomed Gunther Meyer, who previously led the Brussels IP group at Eversheds Sutherland, as a senior counsel in the firm’s IP group. 2 October 2018
Asia
Novartis has teamed up with a clinical-stage biopharmaceutical firm in efforts to bring the Swiss company’s proprietary cancer treatment to patients in China. 1 October 2018
Americas
A Brazilian federal judge has granted a preliminary injunction against a patent for US-based Gilead’s Sovaldi drug, used to treat hepatitis C, following a complaint by a presidential candidate. 27 September 2018
Americas
While personalised medicine is a challenging area for drug developers, there are a number of potential solutions, as LSIPR finds out. 27 September 2018
Americas
‘Evergreening’, ‘delinking’ and a UN report on access to medicines were all up for debate yesterday, during a panel session at the 2018 AIPPI World Congress in Cancún, Mexico. 26 September 2018
Americas
DLA Piper has added two partners from Hogan Lovells to its IP and technology practice in New York. 25 September 2018
Pharma
The World Intellectual Property Organization and the International Federation of Pharmaceutical Manufacturers & Associations today launched an online tool designed to provide information on medical patents. 25 September 2018
Pharma
The EU General Court today rejected a trademark appeal brought by Swiss pharmaceutical company Novartis. 25 September 2018